A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Edward Conard Biography and Net Worth

Director of Waters

Edward W. Conard is Independent Director of Waters Corporation, since August 1994. He has been an independent director and investor since January 2008. Mr. Conard was a Managing Director of Bain Capital, LLC from March 1993 to December 2007. Mr. Conard was previously a Director of Wasserstein Perella & Co., Inc., an investment banking firm that specializes in mergers and acquisitions, and a Vice President of Bain & Company heading up the firm’s operations practice area. Mr. Conard’s years of experience as a director and a managing director of two large investment firms affords the Waters Board the benefit of his considerable financial, accounting and business strategy skills.

What is Edward Conard's net worth?: The estimated net worth of Edward Conard is at least $22.21 million as of November 30th, 2022. Mr. Conard owns 74,224 shares of Waters stock worth more than $22,210,048 as of April 22nd. This net worth estimate does not reflect any other assets that Mr. Conard may own. Learn More about Edward Conard's net worth.
How do I contact Edward Conard?: The corporate mailing address for Mr. Conard and other Waters executives is 34 MAPLE STREET, MILFORD MA, 01757. Waters can also be reached via phone at (508) 478-2000 and via email at [email protected]. Learn More on Edward Conard's contact information.
Has Edward Conard been buying or selling shares of Waters?: Edward Conard has not been actively trading shares of Waters during the last quarter. Most recently, Edward Conard sold 1,059 shares of the business's stock in a transaction on Wednesday, November 30th. The shares were sold at an average price of $334.70, for a transaction totalling $354,447.30. Following the completion of the sale, the director now directly owns 74,224 shares of the company's stock, valued at $24,842,772.80. Learn More on Edward Conard's trading history.
Who are Waters' active insiders?: Waters' insider roster includes Linda Baddour (Director), Michael Berendt (Director), Sherry Buck (Former CFO), Robert Carson (SVP), Edward Conard (Director), Michael Harrington (SVP), Ian King (SVP), Christopher Kuebler (Director), Christopher O'Connell (CEO), JoAnn Reed (Director), Thomas Salice (Director), and Mark Vergnano (Director). Learn More on Waters' active insiders.
Are insiders buying or selling shares of Waters?: During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,500 shares worth more than $1,343,690.00. The most recent insider tranaction occured on March, 13th when Director Linda Baddour sold 500 shares worth more than $177,770.00. Insiders at Waters own 0.8% of the company. Learn More about insider trades at Waters.
Information on this page was last updated on 3/13/2024.

Edward Conard Insider Trading History at Waters

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/30/2022	Sell	1,059	$334.70	$354,447.30	74,224
12/2/2021	Sell	4,000	$336.01	$1,344,040.00
12/4/2020	Sell	1,322	$236.59	$312,771.98	71,865
11/26/2019	Sell	1,112	$221.97	$246,830.64	68,510

Edward Conard Buying and Selling Activity at Waters

Waters Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Today's Range

Now: $299.23

$294.71

$300.81

50 Day Range

MA: $335.46

$294.23

$361.00

2 Week Range

Now: $299.23

$231.90

$363.80

Volume

357,769 shs

Average Volume

407,624 shs

Market Capitalization

$17.75 billion

P/E Ratio

27.58

Dividend Yield

N/A

Beta

0.92

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad